Proposed Data Collections Submitted for Public Comment and Recommendations, 65967-65969 [2014-26354]
Download as PDF
<![CDATA[
65967
Federal Register / Vol. 79, No. 215 / Thursday, November 6, 2014 / Notices
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, Grants.gov
(EGOV), Department of Health and
Human Services, announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). The ICR is for a 3 year renewal
of a previously-approved information
collection assigned OMB control
number 4040–0006–SF–424 D
Assurances for Construction Programs,
which expired on June 30, 2014. The
ICR also requests categorizing the form
as a common form, meaning HHS will
only request approval for its own use of
the form rather than aggregating the
burden estimate across all Federal
Agencies as was done for previous
actions on this OMB control number.
Prior to submitting that ICR to OMB,
EGOV seeks comments from the public
regarding the burden estimate, below, or
any other aspect of the ICR.
SUMMARY:
Comments on the ICR must be
received on or before January 5, 2015.
ADDRESSES: Submit your comments to
ed.calimag@hhs.gov or (202) 690–7569.
FOR FURTHER INFORMATION CONTACT:
Ed.Calimag@hhs.gov or (202) 690–7569.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
document identifier HHS–EGOV–
21478–60D for reference.
Information Collection Request Title:
SF–424 D Assurances for Construction
Programs.
Abstract: SF–424 D Assurances for
Construction Programs is used as
certification of assurances by the grant
applicant when requesting funds for
construction grant programs. Need and
Proposed Use of the Information: The
SF–424 D Assurances for Construction
Programs form is used as certification of
assurances by the grant applicant when
requesting funds for non-construction
grant programs. The Federal awarding
DATES:
agencies use information submitted on
this form for award determination of the
Federal assistance awards programs.
Likely Respondents: Federal grant
applicants.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions, to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information, to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information, and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
5,694
Total ..........................................................................................................
Grants.gov specifically requests
comments on (1) the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, (2) the accuracy
of the estimated burden, (3) ways to
enhance the quality, utility, and clarity
of the information to be collected, and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Darius Taylor,
Information Collection Clearance Officer.
[FR Doc. 2014–26376 Filed 11–5–14; 8:45 am]
BILLING CODE 4150–37–P
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Determination Concerning a Petition to
Add a Class of Employees to the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services (HHS).
AGENCY:
VerDate Sep<11>2014
19:46 Nov 05, 2014
Jkt 235001
ACTION:
1
1
5,694
5,694
1
1
5,694
Notice.
HHS gives notice of a
determination concerning a petition to
add a class of employees from the
Simonds Saw and Steel Company in
Lockport, New York, to the Special
Exposure Cohort (SEC) under the Energy
Employees Occupational Illness
Compensation Program Act of 2000
(EEOICPA).
FOR FURTHER INFORMATION CONTACT:
Stuart L. Hinnefeld, Director, Division
of Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 1090
Tusculum Avenue, MS C–47,
Cincinnati, OH 45226–1938, Telephone
1–877–222–7570. Information requests
can also be submitted by email to
DCAS@CDC.GOV.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Authority: [42 U.S.C.7384q].
On October 9, 2014, the Secretary of
HHS determined that the following class
of employees does not meet the
statutory criteria for addition to the SEC
as authorized under EEOICPA:
All Atomic Weapons Employer
employees who worked at Simonds Saw
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
and Steel Co. in Lockport, New York,
from January 1, 1958, through December
31, 2006.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2014–26425 Filed 11–5–14; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–15–15DA]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
E:\FR\FM\06NON1.SGM
06NON1
65968
Federal Register / Vol. 79, No. 215 / Thursday, November 6, 2014 / Notices
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy A. Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
mstockstill on DSK4VPTVN1PROD with NOTICES
Proposed Project
‘‘Improving the Impact of Laboratory
Practice Guidelines: A New Paradigm
for Metrics’’—American Society for
Microbiology—NEW—Center for
Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention is funding three 5-year
projects collectively entitled ‘‘Improving
the Impact of Laboratory Practice
Guidelines: A New Paradigm for
Metrics’’. An ‘‘LPG’’ is defined as
written recommendations for voluntary,
standardized approaches for medical
laboratory testing that takes into account
VerDate Sep<11>2014
19:46 Nov 05, 2014
Jkt 235001
processes for test selection, sample
procurement and processing, analytical
methods, and results reporting for
effective diagnosis and management of
disease and health conditions. LPGs
may be disseminated to, and used by,
laboratorians and clinicians to assist
with test selection and test result
interpretation. The overall purpose of
these cooperative agreements is to
increase the effectiveness of LPGs by
defining measures and collecting
information to inform better LPG
creation, revision, dissemination,
promotion, uptake and impact on
clinical testing and public health. The
project will explore how these processes
and their impediments and facilitators
differ among various intended users of
LPGs. Through this demonstration
project, CDC seeks to understand how to
customize LPG creation and promotion
to better serve these intended users of
LPGs. An important goal is to help
organizations that sponsor the
development of LPGs create a
sustainable approach for continuous
quality improvement to evaluate and
improve an LPG’s impact through better
collection of information.
The CDC selected three organizations
that currently create and disseminate
LPGs to support activities under a
cooperative agreement funding
mechanism to improve the impact of
their LPGs. The American Society for
Microbiology (ASM), the Clinical and
Laboratory Standards Institute, and the
College of American Pathologists, will
each use their LPGs as models to better
understand how to improve uptake and
impact of these and future LPGs. Only
the ASM submission will be described
in this notice.
The ASM project will address four
LPGs that are important to clinical
testing and have a high public health
impact: Reducing blood culture
contamination (BCC), rapid diagnosis of
blood stream infections (BSI), proper
collection and transport of urine (UT),
and microbiological practices to
improve the diagnosis and management
of patients with Clostridium difficile (C.
difficile) infection (CDI). The BCC LPG
was published and it includes
recommendations for the use of: (1)
Venipuncture over catheters as the
preferred technique for sample
collection in a clinical setting, and (2)
phlebotomy teams over nonphlebotomist staff for collecting blood
for culture. The BSI report examines the
effectiveness of rapid diagnostic tests to
promote more accurate and timely
administration of targeted antibiotic
therapy for patients with bloodstream
infections. This report will be published
and recommendations will be
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
developed based on additional
information collected. Practices related
to the collection, storage and
preservation of urine for microbiological
culture that improve the diagnosis and
management of patients with urinary
tract infections were analyzed and
approved recommendations will be
published. Microbiological practices
related to improving diagnosis and
management of patients with C. difficile
infection will be collected and analyzed,
and recommendations will also be
developed and published.
The intended respondents of ASM’s
surveys will include microbiology
supervisors, laboratory directors, and
laboratory managers. For this request for
OMB approval of a new information
collection, we will be requesting
approval to collect baseline and postdissemination information for the BCC
LPG. Because the BSI, UT and CDI
reports are not yet published, ASM will
conduct a baseline survey to determine
current practices prior to dissemination
of the LPGs.
On behalf of the ASM and the CDC,
the Laboratory Response Network
(LRN), which was founded by the CDC,
will recruit laboratories that perform the
kinds of testing affected by these LPGs
to take the surveys. Messages regarding
ASM surveys will be worded as an
invitation, not as a coercive request.
Some states may opt not to recruit LRN
laboratory participation, but because the
issues are important to clinical and
public health, we expect good
participation by most states. This
mechanism will assure the best
response rate of all the options we
considered.
The CDC LRN Coordinator will email
a letter to the Laboratory Director of the
LRN Reference Laboratories, (i.e., 50
State Public Health Laboratories, the
New York City Public Health Laboratory
and the Los Angeles County Public
Health Laboratory). These 52 LRN
Reference Laboratory Directors will be
asked to then email the sentinel
laboratories, which include hospital and
independent laboratories, in their states,
and provide a hyperlink to access the
survey tool on-line via a landing page
provided by ASM through their Clinical
Microbiology portal. Survey Monkey
will be used as the data collection
instrument and responses will be
collected and maintained by ASM. We
anticipate that a maximum of 4,200
sentinel laboratories will be contacted
and asked to complete the survey online. ASM anticipates achieving an 80%
response rate with their information
collections, or 3,360 out of ∼4,200
aggregate responses for each of the 5
different surveys.
E:\FR\FM\06NON1.SGM
06NON1
65969
Federal Register / Vol. 79, No. 215 / Thursday, November 6, 2014 / Notices
For burden calculations, we assume
one respondent per laboratory and we
also assume respondents will include
microbiology supervisors, laboratory
directors, and laboratory managers,
approximately in a 50%:25%:25%
distribution, respectively. According to
ASM, the burden hours per respondent
who will be invited to participate in the
BCC baseline and post-dissemination
surveys and the BSI, UT and CDI
baseline surveys will be 20 minutes.
This time frame was specified based on
ASM’s previous experiences conducting
laboratory surveys. Each survey will be
pilot tested with 9 or fewer respondents
before dissemination to assure that
completing the surveys does not extend
past 20 minutes.
CDC is requesting a three-year OMB
approval to collect this information.
There are no costs to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Microbiology Supervisors .....................................
BCC ..............................
BSI ................................
UT .................................
CDI ................................
BCC ..............................
BSI ................................
UT .................................
CDI ................................
BCC ..............................
BSI ................................
UT .................................
CDI ................................
Laboratory Directors .............................................
Laboratory Managers ...........................................
[FR Doc. 2014–26354 Filed 11–5–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–15–0931]
mstockstill on DSK4VPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy A. Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
VerDate Sep<11>2014
19:46 Nov 05, 2014
Jkt 235001
2,100
2,100
2,100
2,100
1,050
1,050
1,050
1,050
1,050
1,050
1,050
1,050
2
1
1
1
2
1
1
1
2
1
1
1
20/60
20/60
20/60
20/60
20/60
20/60
20/60
20/60
20/60
20/60
20/60
20/60
1,400
700
700
700
700
350
350
350
700
350
350
350
........................
........................
7,000
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
PO 00000
Total burden
(in hours)
........................
Total ...............................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Type of respondent
Frm 00048
Fmt 4703
Sfmt 4703
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
Healthy Homes and Lead Poisoning
Surveillance System (HHLPSS) (OMB
No. 0920–0931, expires 04/30/2015)—
Extension—National Center for
Environmental Health (NCEH), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The overarching goal of the Healthy
Homes and Lead Poisoning Surveillance
System (HHLPSS) is to support healthy
homes surveillance activities at the state
and national levels. CDC is requesting a
three-year extension of Office of
Management and Budget (OMB)
approval for up to 40 state and local
Healthy Homes Childhood Lead
Poisoning Prevention Programs (CLPPP)
and the state-based Adult Blood Lead
Epidemiology and Surveillance (ABLES)
programs. The programs will report
information (e.g., presence of lead paint,
age of housing, occupation of adults and
type of housing) to the CDC. They will
use the system as designed.
Over the last three years, 7 states have
adopted the HHLPPS and 13 are in betatesting. In October 2014, CDC began
funding 40 state and local blood lead
surveillance programs. Many of these
programs and their subcontractors at the
local level will come on line with
HHLPSS in the next year.
E:\FR\FM\06NON1.SGM
06NON1
]]>Agencies
[Federal Register Volume 79, Number 215 (Thursday, November 6, 2014)]
[Notices]
[Pages 65967-65969]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26354]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-15-15DA]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden, invites the general
public and other Federal agencies to take this opportunity to comment
on proposed and/or continuing information collections, as required by
the Paperwork Reduction Act of 1995. To request more information on the
below
[[Page 65968]]
proposed project or to obtain a copy of the information collection plan
and instruments, call 404-639-7570 or send comments to Leroy A.
Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an
email to omb@cdc.gov.
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information. Written comments should be received within 60
days of this notice.
Proposed Project
``Improving the Impact of Laboratory Practice Guidelines: A New
Paradigm for Metrics''--American Society for Microbiology--NEW--Center
for Surveillance, Epidemiology and Laboratory Services (CSELS), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention is funding three 5-
year projects collectively entitled ``Improving the Impact of
Laboratory Practice Guidelines: A New Paradigm for Metrics''. An
``LPG'' is defined as written recommendations for voluntary,
standardized approaches for medical laboratory testing that takes into
account processes for test selection, sample procurement and
processing, analytical methods, and results reporting for effective
diagnosis and management of disease and health conditions. LPGs may be
disseminated to, and used by, laboratorians and clinicians to assist
with test selection and test result interpretation. The overall purpose
of these cooperative agreements is to increase the effectiveness of
LPGs by defining measures and collecting information to inform better
LPG creation, revision, dissemination, promotion, uptake and impact on
clinical testing and public health. The project will explore how these
processes and their impediments and facilitators differ among various
intended users of LPGs. Through this demonstration project, CDC seeks
to understand how to customize LPG creation and promotion to better
serve these intended users of LPGs. An important goal is to help
organizations that sponsor the development of LPGs create a sustainable
approach for continuous quality improvement to evaluate and improve an
LPG's impact through better collection of information.
The CDC selected three organizations that currently create and
disseminate LPGs to support activities under a cooperative agreement
funding mechanism to improve the impact of their LPGs. The American
Society for Microbiology (ASM), the Clinical and Laboratory Standards
Institute, and the College of American Pathologists, will each use
their LPGs as models to better understand how to improve uptake and
impact of these and future LPGs. Only the ASM submission will be
described in this notice.
The ASM project will address four LPGs that are important to
clinical testing and have a high public health impact: Reducing blood
culture contamination (BCC), rapid diagnosis of blood stream infections
(BSI), proper collection and transport of urine (UT), and
microbiological practices to improve the diagnosis and management of
patients with Clostridium difficile (C. difficile) infection (CDI). The
BCC LPG was published and it includes recommendations for the use of:
(1) Venipuncture over catheters as the preferred technique for sample
collection in a clinical setting, and (2) phlebotomy teams over non-
phlebotomist staff for collecting blood for culture. The BSI report
examines the effectiveness of rapid diagnostic tests to promote more
accurate and timely administration of targeted antibiotic therapy for
patients with bloodstream infections. This report will be published and
recommendations will be developed based on additional information
collected. Practices related to the collection, storage and
preservation of urine for microbiological culture that improve the
diagnosis and management of patients with urinary tract infections were
analyzed and approved recommendations will be published.
Microbiological practices related to improving diagnosis and management
of patients with C. difficile infection will be collected and analyzed,
and recommendations will also be developed and published.
The intended respondents of ASM's surveys will include microbiology
supervisors, laboratory directors, and laboratory managers. For this
request for OMB approval of a new information collection, we will be
requesting approval to collect baseline and post-dissemination
information for the BCC LPG. Because the BSI, UT and CDI reports are
not yet published, ASM will conduct a baseline survey to determine
current practices prior to dissemination of the LPGs.
On behalf of the ASM and the CDC, the Laboratory Response Network
(LRN), which was founded by the CDC, will recruit laboratories that
perform the kinds of testing affected by these LPGs to take the
surveys. Messages regarding ASM surveys will be worded as an
invitation, not as a coercive request. Some states may opt not to
recruit LRN laboratory participation, but because the issues are
important to clinical and public health, we expect good participation
by most states. This mechanism will assure the best response rate of
all the options we considered.
The CDC LRN Coordinator will email a letter to the Laboratory
Director of the LRN Reference Laboratories, (i.e., 50 State Public
Health Laboratories, the New York City Public Health Laboratory and the
Los Angeles County Public Health Laboratory). These 52 LRN Reference
Laboratory Directors will be asked to then email the sentinel
laboratories, which include hospital and independent laboratories, in
their states, and provide a hyperlink to access the survey tool on-line
via a landing page provided by ASM through their Clinical Microbiology
portal. Survey Monkey will be used as the data collection instrument
and responses will be collected and maintained by ASM. We anticipate
that a maximum of 4,200 sentinel laboratories will be contacted and
asked to complete the survey on-line. ASM anticipates achieving an 80%
response rate with their information collections, or 3,360 out of
~4,200 aggregate responses for each of the 5 different surveys.
[[Page 65969]]
For burden calculations, we assume one respondent per laboratory
and we also assume respondents will include microbiology supervisors,
laboratory directors, and laboratory managers, approximately in a
50%:25%:25% distribution, respectively. According to ASM, the burden
hours per respondent who will be invited to participate in the BCC
baseline and post-dissemination surveys and the BSI, UT and CDI
baseline surveys will be 20 minutes. This time frame was specified
based on ASM's previous experiences conducting laboratory surveys. Each
survey will be pilot tested with 9 or fewer respondents before
dissemination to assure that completing the surveys does not extend
past 20 minutes.
CDC is requesting a three-year OMB approval to collect this
information. There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Microbiology Supervisors...... BCC............. 2,100 2 20/60 1,400
BSI............. 2,100 1 20/60 700
UT.............. 2,100 1 20/60 700
CDI............. 2,100 1 20/60 700
Laboratory Directors.......... BCC............. 1,050 2 20/60 700
BSI............. 1,050 1 20/60 350
UT.............. 1,050 1 20/60 350
CDI............. 1,050 1 20/60 350
Laboratory Managers........... BCC............. 1,050 2 20/60 700
BSI............. 1,050 1 20/60 350
UT.............. 1,050 1 20/60 350
CDI............. 1,050 1 20/60 350
---------------------------------------------------------------
Total..................... .............. .............. .............. 7,000
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-26354 Filed 11-5-14; 8:45 am]
BILLING CODE 4163-18-P
